SS

Simone Steiner

Chief Technical Officer

Transgene

Basel, Basel-Stadt


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Transgene
Industry
biotechnology
Employees
210.0
Seniority
C suite
Annual Revenue
10332000.0

Technologies

Outlook Microsoft Office 365 Google Tag Manager Mobile Friendly Adobe Media Optimizer WordPress.org Cedexis Radar Vimeo Apache Viewpoint

Keywords

biotechnology life sciences immunotherapy cancer treatment personalized vaccines oncology genetic engineering tg4050 tg4001 tg6050 bt-001 myvac platform invir.io platform oncolytic viruses ai in medicine clinical trials immune response anticancer therapy hpv-related cancer tumor-targeted treatment solid tumors virus-based therapies therapeutic vaccines immune checkpoint inhibitors cytokines interleukin 12 anti-ctla4 viral vectors clinical efficacy patient-specific treatment cancer immunology drug safety therapeutic antibodies tumor microenvironment tumor regression antigen-specific responses viral oncolytics neoadjuvant therapy macrophage polarization cancer vaccines cancer research therapeutic approaches cancer immunotherapy biological products adjuvant therapy molecular engineering therapeutic modalities clinical efficacy studies neoadjuvant immunotherapy cancer vaccine development viral vector technology individualized neoantigen vaccines precision medicine clinical-stage personalized immunotherapy drug development cancer patients biopharmaceutical partnerships advanced cancer care viral vector engineering therapeutic candidates healthcare providers patient-specific treatments innovative therapies immune system stimulation unmet medical needs environmental responsibility corporate social responsibility strategic collaborations ai-driven neoantigen prediction euronext paris hospital & health care health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans